SPAC Carnage Continues, MTAC and Memic Call off Deal

by BA Research | Mar 10, 2022 | SPACs

The 11th cancelled deal of 2022 highlights the day in SPACs. We recap all the news. ————————————————-Free Investor Resources from Boardroom...

In the Earnings Spotlight: Rivian Automotive (RIVN)

by BA Research | Mar 10, 2022 | Earnings

Revenues and earnings won’t matter. RIVN must prove it can start churning deliveries. RIVN reports Q4 earnings today aftermarket. Consensus calls for $(2.05) on sales of $64 million. These numbers don’t matter. The only metric investors will be watching for is...

In the Earnings Spotlight: Cepton (CPTN)

by BA Research | Mar 10, 2022 | Earnings, SPACs

If you like juice, fine. If you like fundamentals, LiDAR is still a next-year story Key points ahead of the quarter CPTN reports Q4 earnings today aftermarket. Cepton appears to have the relations in pace to make it into the winner’s circle. LiDAR maker Cepton (CPTN)...

Tims China gets a haircut in SLCR SPAC Deal

by BA Research | Mar 9, 2022 | SPACs

Amidst SPAC meltdown, LBBB prices $60M IPO. SLCR cuts valuation on Tims China, GLAQ extends. And all the day’s news in SPACs. ————————————————-Free Investor Resources...

Activist Alert: Cano Health (CANO)

by BA Research | Mar 9, 2022 | Activism

Daniel Loeb targets Cano Health. As the deSPAC firesale rages on, let the arbitrage begin. Cano Health (CANO) is trading up ~38% intraday after Daniel Loeb’s Third Point disclosed an  increased stake in the company to 1.5M shares. Given the shares’ recent...